BG Medicine Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2011
2012
2013
2014
2015
Sales/Revenue
1,634.00
2,815.00
4,073.00
2,787.00
1,566.00
Cost of Goods Sold (COGS) incl. D&A
619.00
957.00
1,389.00
956.00
505.00
Gross Income
1,015.00
1,858.00
2,684.00
1,831.00
1,061.00
SG&A Expense
18,500.00
24,586.00
17,058.00
9,193.00
5,534.00
EBIT
17,485.00
22,728.00
14,374.00
7,362.00
4,473.00
Unusual Expense
39.00
-
345.00
-
565.00
Non Operating Income/Expense
-
20.00
217.00
24.00
106.00
Interest Expense
89.00
1,083.00
928.00
728.00
159.00
Pretax Income
17,582.00
23,769.00
15,849.00
8,064.00
5,303.00
Consolidated Net Income
17,582.00
23,769.00
15,849.00
8,064.00
5,303.00
Net Income
17,582.00
23,769.00
15,849.00
8,064.00
5,303.00
Net Income After Extraordinaries
17,582.00
23,769.00
15,849.00
8,064.00
5,303.00
Net Income Available to Common
17,700.00
23,769.00
15,849.00
8,064.00
6,958.00
EPS (Basic)
4.00
4.70
2.33
0.99
0.72
Basic Shares Outstanding
4,409.50
5,054.00
6,803.20
8,175.80
9,609.40
EPS (Diluted)
4.01
4.70
2.33
0.99
0.72
Diluted Shares Outstanding
4,409.50
5,054.00
6,803.20
8,175.80
9,609.40
EBITDA
17,065.00
22,455.00
14,209.00
7,231.00
4,386.00
Non-Operating Interest Income
31.00
22.00
15.00
2.00
-
Preferred Dividends
118.00
-
-
-
1,655.00
About BG Medicine
View Profile
